Mednet Logo
HomePrimary CareQuestion

When do you avoid or stop erythropoietin-stimulating agents in patients with anemia and end stage kidney disease?

1 Answers
Mednet Member
Mednet Member
Nephrology · University Of California San Francisco Medical Center At Parnassus

For the most part, I don't. If the patient has uncontrolled hypertension, then I would air on the side of using less and possibly even not giving it. In patients with cancer, I always check with hem/onc to see if it is okay to give it. Most of the time, I find that they don't have a problem giving i...

Register or Sign In to see full answer